SymBiosis II
Venture Capital
Bentonville, Arkansas biotherapeutics venture capital firm investing in bioengineering and serious disease treatments.
Bentonville, United States · 3+ investments
Seed
Early Stage
Growth
Biotech
Biotherapeutics
Life Sciences
- Headquarters
- Bentonville, United States
- Founded
- 2021
- Website
- symbiosis.vc
- AUM
- $357.0M
- Total Investments
- 3
- Last Investment
- Aug 2022
- Geographic Focus
- United States
Investment Thesis
Early-stage biotherapeutics investing focused on advancing innovations for serious and life-threatening diseases through conviction-led funding.
SymBiosis II is a Venture Capital firm based in Bentonville, United States. It has made 3 investments in Biotech and Biotherapeutics.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.